Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer: Rationale, Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758834017702820
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 16, 2017
Authors
Publisher
SAGE Publications